Intranasal live-attenuated influenza vaccine (LAIV) is unlikely to cause egg-mediated allergic reactions in egg-allergic children

Paul Turner*, Michel Erlewyn-Lajeunesse

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

4 Citations (Scopus)
Original languageEnglish
Pages (from-to)312-313
Number of pages2
JournalJournal of Allergy and Clinical Immunology: In Practice
Volume3
Issue number2
DOIs
Publication statusPublished - 1 Mar 2015

Bibliographical note

Funding Information:
This report is independent research commissioned and funded by the Department of Health Policy Research Programme (National Vaccine Evaluation Consortium, 039/0031). The views expressed in this publication are those of the author(s) and not necessarily those of the Department of Health.

Funding Information:
P. J. Turner is in receipt of a Clinician Scientist award funded by the UK Medical Research Council (Grant reference MR/K010468/1) and has received research support from the Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre awards to Imperial College London Healthcare NHS Trust.

Funding Information:
Conflicts of interest: P. J. Turner has received research support from the Department of Health , NHS National Institute for Health Research , and UK Medical Research Council . M. Erlewyn-Lajeunesse has received support for attendance at scientific meetings from Allergy Therapeutics , ALK Albelo , MEDA Pharmaceuticals , and Thermo Fisher .

Cite this